Clinical Trials Directory

Trials / Completed

CompletedNCT04035564

Early Sodium Intake in Preterm Newborns

Early Sodium Intake in Preterm Newborns; Randomized Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Hospital del Niño "Dr. Federico Gomez Santos" · Academic / Other
Sex
All
Age
24 Hours
Healthy volunteers
Not accepted

Summary

Hyponatremia is a common complication among preterm infants, renal losses of sodium contribute to the development of hyponatremia in preterm newborns. Sodium imbalances impact in newborns outcome. There is controversy about the time of initiation and the requirements of sodium in premature infants. Hypothesis: early (24 hours of life) sodium supplementation (5mEq/kg/day) prevents the develop of hyponatremia in preterm infants.

Detailed description

This study is a randomized controlled trial in infants less than 35 weeks gestation admitted to the Newborn Intensive Care Unit at Children Hospital in Saltillo Coahuila Mexico. Infants receive at 24 hours of life; sodium (5mEq/kg/day) versus less than 1mEq/kg/day. Weight, serum and urine sodium, serum chloride, serum and urine creatinine, serum chloride, bicarbonate and glucose are monitored daily during the first 3 days of life. Patients are assessed for hyponatremia, hypernatremia, weight change, sepsis, necrotizing enterocolitis and intraventricular hemorrhage.

Conditions

Interventions

TypeNameDescription
DRUGSodium < 1mEq/kg/daySodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life 1
DRUGSodium 5mEq/kg/daySodium administration enteral and/or parenteral 5mEq/kg/day started on day of life 1

Timeline

Start date
2018-03-30
Primary completion
2020-03-02
Completion
2020-03-20
First posted
2019-07-29
Last updated
2020-04-21
Results posted
2020-04-08

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT04035564. Inclusion in this directory is not an endorsement.